iohexol has been researched along with Obesity in 10 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Excerpt | Relevance | Reference |
---|---|---|
" GFR was estimated with the Chronic Kidney Disease and Epidemiology equation (CKD-EPI) and measured with a gold standard method (inulin or iohexol) not indexed (mGFR) or indexed to body surface area determined by the Dubois and Dubois formula with either real (mGFRr) or ideal (mGFRi) body weight." | 3.80 | Accuracy of GFR estimation in obese patients. ( Dubourg, L; Guebre-Egziabher, F; Hadj-Aissa, A; Juillard, L; Lemoine, S; Nguyen-Tu, MS; Sens, F, 2014) |
"Iohexol disposition was measured using population pharmacokinetics." | 2.75 | Measuring the glomerular filtration rate in obese individuals without overt kidney disease. ( Brizendine, EJ; Friedman, AN; Gomez, G; Hall, S; Inman, M; Li, L; Moe, S; Perkins, SM; Quinney, SK; Shihabi, Z; Strother, M, 2010) |
"Proteinuria was in the nephrotic range in 44 and the BMI exceeded the 95th percentile in 57 patients of this cohort." | 1.36 | Dyslipidemia in children with chronic kidney disease. ( Flynn, JT; Furth, SL; Goebel, J; Kupferman, JC; Mitsnefes, MM; Pierce, CB; Saland, JM; Warady, BA, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (80.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Delanaye, P | 1 |
Cavalier, E | 1 |
Bouquegneau, A | 1 |
Friedman, AN | 2 |
Moe, S | 2 |
Fadel, WF | 1 |
Inman, M | 2 |
Mattar, SG | 1 |
Shihabi, Z | 2 |
Quinney, SK | 2 |
Lemoine, S | 1 |
Guebre-Egziabher, F | 1 |
Sens, F | 1 |
Nguyen-Tu, MS | 1 |
Juillard, L | 1 |
Dubourg, L | 1 |
Hadj-Aissa, A | 1 |
Pan, YN | 1 |
Li, AJ | 1 |
Chen, XM | 1 |
Wang, J | 1 |
Ren, DW | 1 |
Huang, QL | 1 |
Schummer, C | 1 |
Sakr, Y | 1 |
Steenbeck, J | 1 |
Gugel, M | 1 |
Reinhart, K | 1 |
Schummer, W | 1 |
Strother, M | 1 |
Hall, S | 1 |
Perkins, SM | 1 |
Brizendine, EJ | 1 |
Gomez, G | 1 |
Li, L | 1 |
Saland, JM | 1 |
Pierce, CB | 1 |
Mitsnefes, MM | 1 |
Flynn, JT | 1 |
Goebel, J | 1 |
Kupferman, JC | 1 |
Warady, BA | 1 |
Furth, SL | 1 |
Saremi, F | 1 |
Mekhail, S | 1 |
Sefidbakht, S | 1 |
Thonar, B | 1 |
Malik, S | 1 |
Sarlaty, T | 1 |
Kligerman, S | 1 |
Mehta, D | 1 |
Farnadesh, M | 1 |
Jeudy, J | 1 |
Olsen, K | 1 |
White, C | 1 |
Spallarossa, P | 1 |
Cordera, R | 1 |
Andraghetti, G | 1 |
Bertero, G | 1 |
Brunelli, C | 1 |
Caponnetto, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Open, Randomized, Unicenter Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease[NCT04626323] | Phase 2 | 60 participants (Anticipated) | Interventional | 2021-05-25 | Recruiting | ||
Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)[NCT00327860] | 1,100 participants (Actual) | Observational | 2003-10-31 | Active, not recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for iohexol and Obesity
Article | Year |
---|---|
Risk of extravasation after power injection of contrast media via the proximal port of multilumen central venous catheters: case report and review of the literature.
Topics: Adult; Catheterization, Central Venous; Contrast Media; Extravasation of Diagnostic and Therapeutic | 2010 |
2 trials available for iohexol and Obesity
Article | Year |
---|---|
Coronary Computed Tomographic Angiography at Low Concentration of Contrast Agent and Low Tube Voltage in Patients with Obesity:: A Feasibility Study.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Artery Disease; Feasi | 2016 |
Measuring the glomerular filtration rate in obese individuals without overt kidney disease.
Topics: Adult; Biomarkers; Body Mass Index; Body Surface Area; Creatinine; Cross-Sectional Studies; Cystatin | 2010 |
7 other studies available for iohexol and Obesity
Article | Year |
---|---|
The ideal drug dosage adaptation through estimated glomerular filtration rate in obese patients? Measuring GFR is the key.
Topics: Creatinine; Glomerular Filtration Rate; Humans; Iohexol; Obesity | 2022 |
Predicting the glomerular filtration rate in bariatric surgery patients.
Topics: Adult; Bariatric Surgery; Body Surface Area; Body Weight; Creatinine; Cystatin C; Female; Glomerular | 2014 |
Accuracy of GFR estimation in obese patients.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Body Surface Area; Body Weight; Contrast Media; Fem | 2014 |
Dyslipidemia in children with chronic kidney disease.
Topics: Adolescent; Age Factors; Biomarkers; Body Mass Index; Chi-Square Distribution; Child; Child, Prescho | 2010 |
Quantification of epicardial adipose tissue: correlation of surface area and volume measurements.
Topics: Adipose Tissue; Cardiac-Gated Imaging Techniques; Contrast Media; Coronary Angiography; Female; Huma | 2011 |
Use of a hybrid iterative reconstruction technique to reduce image noise and improve image quality in obese patients undergoing computed tomographic pulmonary angiography.
Topics: Analysis of Variance; Contrast Media; Female; Humans; Iohexol; Male; Middle Aged; Obesity; Pulmonary | 2013 |
Association between plasma insulin and angiographically documented significant coronary artery disease.
Topics: Age Factors; Blood Glucose; Constriction, Pathologic; Coronary Angiography; Coronary Disease; Fastin | 1994 |